NCT02212964View on ClinicalTrials.gov

Differentiation of Pseudoprogression and True Progression Through High Field Susceptibility Weighted Imaging and R2*

CompletedOBSERVATIONAL
Enrollment

18

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions
Radiation InjuryRadiation Necrosis
Trial Locations (1)

N6G2J9

University of Western Ontario, London

All Listed Sponsors
collaborator

London Regional Cancer Program, Canada

OTHER

collaborator

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

OTHER

lead

Centre for Functional and Metabolic Mapping

OTHER

NCT02212964 - Differentiation of Pseudoprogression and True Progression Through High Field Susceptibility Weighted Imaging and R2* | Biotech Hunter | Biotech Hunter